Patent · US Active

Site-specific antibody conjugation methods and compositions

US10035853B2 · kind B2 · utility

8Cited by
78References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 29, 2016
Grant dateJul 31, 2018
Priority date—
Expiry dateFeb 29, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.